Natco Pharma Ltd.

NSE: NATCOPHARM | BSE: 524816 | ISIN: INE987B01026 | Industry: Pharmaceuticals
| Value Stock, Under Radar
801.9000 6.50 (0.82%)
NSE Sep 30, 2025 09:07 AM
Volume: 1,139
 

logo
Natco Pharma Ltd.
24 Aug 2018
801.90
0.82%
Geojit Research
NATCO Pharma (NATCO) is a R&D; focussed, vertically integrated pharmaceutical company with an experienced management team and presence across multiple speciality therapeutic segments. Q1FY19 revenue grew by 28% YoY due to stronger performance from domestic (4% vs -20%)) and international formulations(~75%). EBITDA rose by 82% YoY while margin witnessed a 1320bps increase on account of lower raw material cost (RM). PAT growth of 94% YoY is led by lower cost escalations and less...
Geojit BNP Paribas decreased Hold price target of Natco Pharma Ltd. to 940.0 on 17 Sep, 2025.
More from Natco Pharma Ltd.
Recommended